Expression of c-erbB2 and p53 in Curatively Resected Gastric Cancer: Correlation with Clinicopathologic Features and Prognosis

被引:0
|
作者
Hur, Hoon [1 ]
Yi, Jeong Min [1 ]
Lee, In Kyu [1 ]
Song, Kyo Young [1 ]
Kim, Wook [1 ]
Park, Cho Hyun [1 ]
Jeon, Hae Myung [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Surg, Seoul 137701, South Korea
来源
JOURNAL OF THE KOREAN SURGICAL SOCIETY | 2011年 / 80卷 / 03期
关键词
Gastric adenocarcinoma; p53; c-erbB-2; Prognosis; SHORT-TERM PROGNOSIS; TUMOR-RELATED GENES; MUTANT P53; PROTEIN; SUPPRESSOR; MUTATIONS; GROWTH; IMMUNOREACTIVITY; OVEREXPRESSION; ONCOPROTEIN;
D O I
10.4174/jkss.2011.80.3.172
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: We investigated the correlation between expression of c-erbB-2 and p53 proteins and chnicopathologic features of gastric cancer to reveal prognostic factors. Methods: 125 patient records under going curative resection for gastric carcinoma at our institution from January 2000 to June 2003 were collected. Surgical specimens embedded in paraffin block were evaluated for p53 and c-erbB-2 protein as detected by immunohistochemistry. Results: Samples from 30 cases (24.0%) of 125 patients with gastric adenocarcinomas demonstrated positive staining for c-erbB-2 and 72 patients (57.6%) showed positive nuclear staining for p53 protein. c-erbB-2 stained tumors were significantly associated with the depth of tumor invasion (P=0.022), lymph node metastasis (P=0.004) and lymphatic invasion (P=0.019). In a subgroup of patients with gastric carcinoma not exposed to serosa (n=91), expression of both c-erbB-2 and p53 significantly related with poor disease-free survival (OR=5.107) and survival (OR=4.449) in multivariate analysis. Conclusion: When patients with gastric adenocarcinoma showed expression of c-erbB-2 with p53, they were associated with aggressive pathologic features. In the subgroup of patients with gastric adenocarcinoma that did not involve serosa, expression of c-erbB-2 combined with p53 could become a predictive factor for recurrence and survival in multivariate analysis. (J Korean Surg Soc 2011;80:172-181)
引用
收藏
页码:172 / 181
页数:10
相关论文
共 50 条
  • [21] Expression of C-erbB receptors (EGF-R, C-erbB2), TGF alpha and P53 in experimental hepatocarcinogenesis
    Birk, D
    Formentini, A
    Buck, A
    Gansauge, F
    Beger, HG
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 195 - 199
  • [22] Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; No correlation with prognosis
    Hardwick, RH
    Barham, CP
    Ozua, P
    Newcomb, PV
    Savage, P
    Powell, R
    Rahamin, J
    Alderson, D
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (01): : 30 - 35
  • [23] Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer
    Sanz-Ortega, J
    Steinberg, SM
    Moro, E
    Saez, M
    Lopez, JA
    Sierra, E
    Sanz-Esponera, J
    Merino, MJ
    HISTOLOGY AND HISTOPATHOLOGY, 2000, 15 (02) : 455 - 462
  • [24] Relationship of c-erbB-2 expression to clinicopathological features and prognosis in gastric cancer
    Karayiannakis, AJ
    Syrigos, KN
    Chatzigianni, E
    Valinos, P
    Bousiakos, P
    Balas, G
    Lakiotis, G
    Simatos, G
    3RD INTERNATIONAL GASTRIC CANCER CONGRESS, 1999, : 269 - 272
  • [25] Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients
    Xu, Yujin
    Wang, Liancong
    Zheng, Xiao
    Liu, Guan
    Wang, Yuezhen
    Lai, Xiaojing
    Li, Jianqiang
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 487 - 492
  • [26] Cytoplasmic localization of BAG-1 in leukoplakia and carcinoma of the tongue: correlation with p53 and c-erbB2 in carcinoma
    Vora, H. H.
    Mehta, S. V.
    Shah, K. N.
    Brahmbhatt, B. V.
    Desai, N. S.
    Shukla, S. N.
    Shah, P. M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (02): : 100 - 107
  • [27] C-ERBB2 MESSENGER-RNA EXPRESSION IN HUMAN BREAST-TUMORS - COMPARISON WITH C-ERBB2 DNA AMPLIFICATION AND CORRELATION WITH PROGNOSIS
    PARKES, HC
    LILLYCROP, K
    HOWELL, A
    CRAIG, RK
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 39 - 45
  • [28] COMPARISON OF THE MOLECULAR-GENETICS OF STOMACH-CANCER IN BRITAIN AND JAPAN - C-ERBB2 AND P53
    MCCULLOCH, P
    OCHIAI, A
    ODOWD, J
    NASH, J
    SASAKO, M
    HIROHASHI, S
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1803 - 1803
  • [29] Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53
    Beenken, SW
    Grizzle, WE
    Crowe, DR
    Conner, MG
    Weiss, HL
    Sellers, MT
    Krontiras, H
    Urist, MM
    Bland, KI
    ANNALS OF SURGERY, 2001, 233 (05) : 630 - 637
  • [30] Clinical importance of p53, PCNA and EGFr expression in resected gastric cancer
    Roviello, F
    Marrelli, D
    Messano, A
    Vindigni, C
    Filipe, MI
    Gallorini, M
    Presenti, L
    Spina, D
    Pinto, E
    Tosi, P
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 537 - 541